Skip to main content

Table 2 Distribution of various NTM species causing CNS manifestations

From: Epidemiology, clinical presentation, and predictors of outcome in nontuberculous mycobacterial central nervous system infection: a systematic review

Type of nontuberculous mycobacteria/species

Total number of patients (N = 112)

Rapid-growing nontuberculous mycobacteria (RGM)

61 (54.5%)

Slow-growing nontuberculous mycobacteria (SGM)

51 (45.5%)

M. avium complex (SGM)

39 (34.8%)

M. fortuitum (RGM)

24 (21.4%)

M. abscessus (RGM)

17 (15.2%)

M. haemophilum (SGM)

7 (6.6%)

M. massiliense (RGM)

6 (5.4%)

M. kansasii (SGM)

4 (3.6%)

M. mucogenicum (RGM)

4 (3.6%)

M. chelonae (RGM)

4 (3.6%)

M. goodii (RGM)

3 (2.7%)

M. bolletii (RGM)

1 (0.9%)

M. simiaea (SGM)

1 (0.9%)

M. immunogenumb (RGM)

1 (0.9%)

M. houstonense (RGM)

1 (0.9%)

  1. a = 40-year-old diabetic male with mixed infection of Mycobacterium simiae and Mycobacterium Haemophilum (both species identified by 16 s ribosomal RNA gene sequencing), b = polymicrobial infection in a brain abscess patient, including 2 rapidly growing NTM species (Mycobacterium immunogenum and Mycobacterium llatzerense)